文献速递临床试验与 GCP基础与转化研究

脊柱骨转移患者同步整合加量调强放疗:随机对照试验研究方案

Intensity-modulated radiotherapy with integrated-boost in patients with bone metastasis of the spine: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-01-22

主要终点为局部肿瘤控制,次要终点包括急慢性不良事件、疼痛缓解、生活质量和疲乏。

要点

  • SBRT采用IMRT联合SIB加量可能安全治疗脊柱骨转移并提高局部肿瘤控制。
  • 主要终点为局部肿瘤控制,次要终点包括不良事件、疼痛、生活质量和疲乏。

核心结论

  • SBRT使用IMRT联合SIB加量可能是治疗脊柱骨转移的安全方式,能提高靶区精度并改善局部肿瘤控制。

主要发现

  • 靶参数在基线、放疗后3个月和6个月测量。

关键数值与推荐

  • 主要终点为评估和比较局部肿瘤控制(通过不同分割方案和肿瘤区域生物剂量)。
  • 次要终点为急性和慢性不良事件、疼痛缓解、生活质量和疲乏。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Stereotactic body radiation therapy (SBRT) using intensity-modulated radiotherapy (IMRT) with dose escalation by simultaneous integrated boost (SIB) can be a safe modality for treating spinal bone metastases with enhanced targeting accuracy and improve local tumor control. METHODS/DESIGN: This is a single-center, prospective, randomized, controlled trial. One hundred and twenty patients with spinal bone metastases will receive palliative radiation therapy at the Heidelberg University Hospital. SBRT will be given in five or ten fractions with or without SIB. Four treatment arms are planned: IMRT with 30 Gy in ten fractions, IMRT with 30 Gy in ten fractions and SIB to 40 Gy, IMRT with 20 Gy in five fractions, and IMRT with 20 Gy in five fractions and SIB to 30Gy in five fractions will be compared. The target parameters will be measured at baseline level and at three and six months after radiation. DISCUSSION: The primary endpoint of this study was to assess and compare the local tumor control (by means of different fractionation schedules and biological doses to the tumor area). Secondary endpoints are acute and chronic adverse events, pain relief, quality of life, and fatigue. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02832765 . Registered on 27 July 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Sprave T, Welte SE, Bruckner T, et al. Intensity-modulated radiotherapy with integrated-boost in patients with bone metastasis of the spine: study protocol for a randomized controlled trial. Trials. 2018. PMID: 29357902. doi:10.1186/s13063-018-2452-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。